Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the cardiovascular research spotlight issue on metabolic cardiomyopathies).1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Herein, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy and discuss several therapies, which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.This article is part of the Mini Review Series from the Varenna 2017 meeting of the Working Group of Myocardial Function of the European Society of Cardiology.

Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology / van der Velden, Jolanda; Tocchetti, Carlo G; Varricchi, Gilda; Bianco, Anna; Sequeira, Vasco; Hilfiker-Kleiner, Denise; Hamdani, Nazha; Leite-Moreira, Adelino F; Mayr, Manuel; Falcão-Pires, Ines; Thum, Thomas; Dawson, Dana K; Balligand, Jean-Luc; Heymans, Stephane. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - 114:10(2018), pp. 1273-1280-1280. [10.1093/cvr/cvy147]

Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

Tocchetti, Carlo G;Varricchi, Gilda;Bianco, Anna;Heymans, Stephane
2018

Abstract

Disturbed metabolism as a consequence of obesity and diabetes may cause cardiac diseases (recently highlighted in the cardiovascular research spotlight issue on metabolic cardiomyopathies).1 In turn, the metabolism of the heart may also be disturbed in genetic and acquired forms of hypertrophic cardiac disease. Herein, we provide an overview of recent insights on metabolic changes in genetic hypertrophic cardiomyopathy and discuss several therapies, which may be explored to target disturbed metabolism and prevent onset of cardiac hypertrophy.This article is part of the Mini Review Series from the Varenna 2017 meeting of the Working Group of Myocardial Function of the European Society of Cardiology.
2018
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology / van der Velden, Jolanda; Tocchetti, Carlo G; Varricchi, Gilda; Bianco, Anna; Sequeira, Vasco; Hilfiker-Kleiner, Denise; Hamdani, Nazha; Leite-Moreira, Adelino F; Mayr, Manuel; Falcão-Pires, Ines; Thum, Thomas; Dawson, Dana K; Balligand, Jean-Luc; Heymans, Stephane. - In: CARDIOVASCULAR RESEARCH. - ISSN 0008-6363. - 114:10(2018), pp. 1273-1280-1280. [10.1093/cvr/cvy147]
File in questo prodotto:
File Dimensione Formato  
2018 van der velden cvy147.pdf

solo utenti autorizzati

Licenza: Accesso privato/ristretto
Dimensione 495.38 kB
Formato Adobe PDF
495.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/719910
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 60
  • ???jsp.display-item.citation.isi??? 53
social impact